List of insiders holdings for APPLIED GENETIC TECHNOLOGIES CORP:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | Carroll Jill Director 10% Owner |
2014-04-01 16:29:10 | 0 1,989,598 |
1,989,598 | Form 4 |
2 | MedImmune Ventures Inc. 10% Owner |
2014-04-01 16:29:48 | 1,464,092 0 |
1,464,092 | Form 4 |
3 | Wu Samuel Director 10% Owner |
2014-04-01 16:31:49 | 0 1,464,092 |
1,464,092 | Form 4 |
4 | INTERWEST PARTNERS VIII LP InterWest Management Partners VIII LLC INTERWEST INVESTORS VIII L P INTERWEST INVESTORS Q VIII LP GIANOS PHILIP T Kliman Gilbert H Holmes W Stephen CASH HARVEY B 10% Owner |
2022-02-14 06:17:31 | 1,414,515 0 |
1,414,515 | Form 13G |
5 | Menichella Daniel L V.P. & Chief Business Officer |
2015-01-26 18:04:05 | 115,972 0 |
115,972 | Form 4 |
6 | Heah Theresa Chief Medical Officer |
2019-07-31 20:51:34 | 100,000 0 |
100,000 | Form 4 |
7 | Feinsod Matthew Exec. VP, Global Strat. & Dev. |
2019-07-31 20:28:19 | 100,000 0 |
100,000 | Form 4 |
8 | Ashe Andrew D. General Counsel |
2017-08-03 18:18:58 | 100,000 0 |
100,000 | Form 4 |
9 | Alta Partners VIII L.P. CHAMPSI FARAH JANNEY DANIEL NOHRA GUY P Alta Partners Management VIII LLC 10% Owner |
2018-05-31 16:55:23 | 51,896 0 |
51,896 | Form 13D |
10 | Sullivan William A. Chief Financial Officer |
2020-08-07 20:11:59 | 50,000 0 |
50,000 | Form 4 |
11 | Shearman Mark S Chief Scientific Officer |
2020-08-18 18:15:53 | 33,277 0 |
33,277 | Form 4 |
12 | Goldstein Michael H. Chief Medical Officer |
2017-07-18 20:39:53 | 25,000 0 |
25,000 | Form 4 |
13 | Chulay Jeffrey D. VP and Chief Medical Officer |
2016-11-02 18:42:09 | 20,400 0 |
20,400 | Form 4 |
14 | Krol Patrick Johan Hendrik Stichting Aescap 2.0 Privium Fund Management B.V. Inspirational Visions B.V. 10% Owner |
2021-02-09 17:01:20 | 17,999 0 |
17,999 | Form 13G |
15 | Magovcevic-Liebisch Ivana Director |
2021-12-02 18:55:13 | 14,000 0 |
14,000 | Form 4 |
16 | Krex Brian General Counsel |
2019-08-19 20:07:07 | 13,000 0 |
13,000 | Form 4 |
17 | ORONSKY ARNOLD L Director |
2017-04-26 13:07:05 | 0 11,208 |
11,208 | Form 4 |
18 | Knop David R. Director, Process Development |
2014-08-04 18:42:32 | 7,648 0 |
7,648 | Form 4 |
19 | PEACOCK BRUCE Director |
2015-12-04 16:34:15 | 6,200 0 |
6,200 | Form 4 |
20 | BULLOCK LAWRENCE E Chief Financial Officer |
2017-08-09 21:54:14 | 4,168 0 |
4,168 | Form 4 |
21 | Robinson James A. Jr. Director |
2022-12-01 09:23:47 | 0 0 |
0 | Form 4 |
22 | VANLENT ANNE Director |
2022-12-01 09:23:04 | 0 0 |
0 | Form 4 |
23 | Rosen James Director |
2022-12-01 09:22:27 | 0 0 |
0 | Form 4 |
24 | Aliski William Director |
2022-12-01 09:21:19 | 0 0 |
0 | Form 4 |
25 | HURWITZ EDWARD Director |
2022-12-01 09:19:33 | 0 0 |
0 | Form 4 |
26 | Hashad Yehia Director |
2022-12-01 09:18:53 | 0 0 |
0 | Form 4 |
27 | Koenig Scott Director |
2022-12-01 09:18:12 | 0 0 |
0 | Form 4 |
28 | Scaria Abraham Chief Scientific Officer |
2022-12-01 09:16:28 | 0 0 |
0 | Form 4 |
29 | Reynolds Gerald Anthony Chief Accounting Officer |
2022-12-01 09:16:52 | 0 0 |
0 | Form 4 |
30 | DOyley-Gay Hope General Counsel |
2022-12-01 09:15:54 | 0 0 |
0 | Form 4 |
31 | Potter Stephen W Chief Business Officer |
2022-12-01 09:16:12 | 0 0 |
0 | Form 4 |
32 | Schneider Susan Chief Medical Officer |
2022-12-01 09:15:33 | 0 0 |
0 | Form 4 |
33 | Lieber Jonathan I Chief Financial Officer |
2022-12-01 09:15:20 | 0 0 |
0 | Form 4 |
34 | Washer Susan B. President and CEO |
2022-12-01 09:14:57 | 0 0 |
0 | Form 4 |
35 | GUYER DAVID R Director |
2014-07-07 12:10:05 | 0 0 |
0 | Form 3 |
36 | GLAXOSMITHKLINE PLC Former 10% Owner |
2020-02-14 16:38:03 | 0 0 |
0 | Form 13D |